The NECST Network Strategic Governance and Advisory Committees will ensure the MRFF endometriosis funding is managed and acquitted in accordance with MRFF Funding Principles and with research governance best practice.
They will also review and approve decisions on the allocation of funding to specific activities, adhering to the grant's project plan, MRFF Funding Principles and relevant codes of practice.
In carrying out any activity in relation to the establishment of the NECST Network and Registry, we are bound by and comply with the following codes and policies:
The National Statement is developed jointly by  (NHMRC), the  (ARC) and Ìý(±«´¡).
Strategic Governance Committee
Chair:Â Prof Kate Leslie AO
FAHMS
Specialist Anaesthetist and Head of Research, Department of Anaesthesia and Pain Management, Royal Melbourne Hospital
Dr Martin Ritossa
MBBS FRANZCOG
Head of Gynaecology, Lyell McEwin Hospital; Lecturer, Flinders Medical Centre, South Australia
Melissa Parker
RN RM MNURS (RESEARCH)
Endometriosis Coordinator and Researcher, Canberra Endometriosis Centre, Centenary Hospital for Women and Children, ACT Health
Dr Rebecca Deans
MBBS MMed (RHHG) FRANZCOG CREI
RANZCOG Representative; Senior Lecturer, School of Women's and Children's Health, UNSW Medicine; Paediatric and Adolescent Gynaecologist, Royal Hospital for Women and the Sydney Children's Hospital
Lesley Freedman
EndoActive, NSW
Community representative
Jessica Taylor
Australian Coalition for Endometriosis (ACE) and QENDO, QLD
Community representative
Megan Thomson
VIC
Community representative
Janet Michelmore AO
BA DipEd
CEO and Patron, Jean Hailes for Women’s Health
Past members
Dr Vijay Roach, MBBS MRCOG FRANZCOG
RANZCOG Representative; President of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG); Senior Lecturer, Northern Clinical School, University of Sydney
A/Prof Louise Hull, BSc PhD MBChB CREI FRANZCOG
Associate Professor in Reproductive Medicine, Robinson Research Institute, University of Adelaide and Women’s and Children’s Hospital
David Lloyd, BA (HONS) MPA
Former CEO, Jean Hailes for Women’s Health
Dr Rachel Mudge, BSc (HONS) PhD
Former Head of Research Partnerships and Philanthropy, Jean Hailes for Women’s Health
Advisory Committee
Chair:Â Prof Jason Abbott
BMed (HONS) FRANZCOG FRCOG PhD
Professor of Gynaecological Surgery, School of Women's and Children's Health, UNSW Medicine
Prof Gita Mishra
BSc MSc PhD
Head of the Epidemiology and Biostatistics Division, Professor of Life Course Epidemiology at the School of Public Health, University of Queensland (UQ) and Director of the Australian Longitudinal Study of Women's Health (ALSWH)
Prof Grant Montgomery
FAHMS FSRB Hon FRSNZ
Professorial Research Fellow, Institute for Molecular Bioscience, The University of Queensland
Prof Peter Rogers
BSc (HONS) PhD
Professor of Women's Health Research, University of Melbourne Department of Obstetrics & Gynaecology, and Research Director Royal Women's Hospital
Andrew Michelmore AO
BEng MA
Chairman of the Board of Directors, Jean Hailes for Women’s Health
Past members
David Lloyd, BA (HONS) MPA
Former CEO, Jean Hailes for Women’s Health
Dr Rachel Mudge, BSc (HONS) PhD
Former Head of Research Partnerships and Philanthropy, Jean Hailes for Women’s Health
Clinical Trials Network Manager (NECST Network)
Dr Cecilia Ng
BSc MHIM PhD
Adjunct Senior Lecturer, School of Women’s and Children’s Health, UNSW Medicine; Honorary Fellow, Global Women’s Health, The George Institute for Global Health
Australian Clinical Trials Alliance (ACTA)
ACTA is the national peak advisory body that was formed to advance the common and shared interests of clinical trials networks, clinical trial coordinating centres and clinical quality registries across discipline and disease boundaries. Its mission is to promote effective and cost-effective healthcare in Australia through investigator-initiated clinical trials and clinical quality registries that generate evidence to support decisions made by health practitioners, policymakers and consumers.
The NECST Network is an Associate Member of ACTA. Prof Jason Abbott is a representative of the Clinical Trial Network Sector Expansion Special Interest Group. Dr Cecilia Ng is a representative of SIGNet, ACTA’s Special Interest Group for Network Managers, and the Registries Special Interest Group.
For more information on ACTA, please visit .
